Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis

Gastroenterology. 2003 Nov;125(5):1379-87. doi: 10.1016/j.gastro.2003.07.013.

Abstract

Background & aims: Previous work has suggested that CD4+ CD28- or costimulation-independent T cells are increased in autoimmune diseases. In this study, we compared frequency and qualitative characteristics of autoreactive costimulation-independent or CD4+ CD28- T cells in primary biliary cirrhosis (PBC) by taking advantage of the well-defined immunodominant autoepitope of the E2 component of pyruvate dehydrogenase (PDC-E2).

Methods: We determined the frequency of costimulation-independent autoreactive T cells that respond to PDC-E2 163-176 and the frequency of CD4+ CD28- T cells. Finally, we determined the role of biliary epithelial cells (BEC) as both an antigen-presenting cell or, alternatively, as a target cell for T-cell-mediated cytotoxicity.

Results: The precursor frequency of costimulation-independent CD4+ T cells that respond to PDC-E2 163-176 and the frequency of CD4+ CD28- T cells were dramatically elevated in PBC. Furthermore, 2 types of T-cell clones that respond to PDC-E2 163-176 emerged from this study. One type was costimulation dependent and the other costimulation independent. Both types of clones lyse BEC in a similar effector target (E/T) ratio distribution. However, BEC did not help the proliferation of any T-cell clones. Furthermore, costimulation-independent T-cell clones do not become anergic by BEC.

Conclusions: In PBC, costimulation-independent autoreactive T cells, which do not become anergic, increase and maintain the autoimmune response. In controls, although autoantigens are expressed on BEC and autoantigen-reactive T cells exist around BEC, autoantigen-reactive T cells are costimulation dependent and will become anergic and maintain peripheral tolerance.

MeSH terms

  • Antigen-Presenting Cells / pathology
  • Autoimmunity*
  • Bile Ducts / immunology
  • Bile Ducts / pathology
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology
  • Cell Division / drug effects
  • Cells, Cultured
  • Clonal Anergy
  • Clone Cells / immunology*
  • Coculture Techniques
  • Cytotoxicity, Immunologic
  • Dihydrolipoyllysine-Residue Acetyltransferase
  • Humans
  • Liver Cirrhosis, Biliary / immunology*
  • Liver Cirrhosis, Biliary / pathology
  • Peptide Fragments / pharmacology
  • Pyruvate Dehydrogenase Complex / pharmacology
  • T-Lymphocytes / immunology*

Substances

  • Peptide Fragments
  • Pyruvate Dehydrogenase Complex
  • Dihydrolipoyllysine-Residue Acetyltransferase